Cargando…
Point of care diagnosis of dry eye disease with a sensitive immunoassay for dual biomarker detection
Dry eye disease (DED) is a multifactorial eye disease with few effective methods for clinical diagnosis and treatment. It is the most common eye disease with significant health challenges of the unprecedented aging population. Recent proteomic studies and clinical research have led to the discovery...
Autores principales: | Zhang, Sydney, Echegoyen, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694066/ https://www.ncbi.nlm.nih.gov/pubmed/36438598 http://dx.doi.org/10.1016/j.bbrep.2022.101396 |
Ejemplares similares
-
Design and Usability Study of a Point of Care mHealth App for Early Dry Eye Screening and Detection
por: Zhang, Sydney, et al.
Publicado: (2023) -
Sensitivity and specificity of a lateral flow immunoassay (LFI) in serum samples for diagnosis of melioidosis
por: Wongsuvan, Gumphol, et al.
Publicado: (2018) -
Chemiluminescence based immunoassay for the detection of heroin and its metabolites
por: Singh, Smritee, et al.
Publicado: (2018) -
Oxygen-Carrying Capacity of Perfluorohexyloctane, a Novel Eye Drop for Dry Eye Disease
por: Stolowich, Neal, et al.
Publicado: (2023) -
Patient stratification using point of care biomarkers in dry eye disease
por: Shetty, Rohit, et al.
Publicado: (2023)